Old Web
English
Sign In
Acemap
>
Paper
>
Risk of Second Primary Malignancy in Multiple Myeloma in the Novel Therapy Era from 15 Years of Cancer Registry
Risk of Second Primary Malignancy in Multiple Myeloma in the Novel Therapy Era from 15 Years of Cancer Registry
2019
Hsin-An Hou
Yanfang Liu
Hong Qiu
Hwei-Fang Tien
Chao-Hsiun Tang
Keywords:
Multiple myeloma
Malignancy
Medicine
Oncology
Cancer registry
Immunology
Internal medicine
Bortezomib
Cancer
Chemotherapy regimen
Thalidomide
second primary cancer
Correction
Source
Cite
Save
Machine Reading By IdeaReader
0
References
0
Citations
NaN
KQI
[]